5′-(3′)-nucleotidase mRNA levels in blast cells are a prognostic factor in acute myeloid leukemia patients treated with cytarabine

Haematologica

Volumn 89, Issue 5, 2004, Pages 617-619

  Galmarini, Carlos María ^a   Cros, Emeline ^a   Graham, Kathryn ^b   Thomas, Xavier ^c   Mackey, John R ^b   Dumontet, Charles ^a  

^a INSERM   (France)

^b CROSS CANCER INSTITUTE   (Canada)

^c INSERM 590 ^*

Author keywords

5 nucleotidases; Cytarabine; Drug resistance; Leukemia; Nucleoside analogs

Indexed keywords

3' NUCLEOTIDASE; 5' NUCLEOTIDASE; CYTARABINE; MESSENGER RNA; UNCLASSIFIED DRUG; ANTINEOPLASTIC ANTIMETABOLITE; NUCLEOTIDASE;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; BLAST CELL; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; DRUG SENSITIVITY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RNA ISOLATION; ACUTE DISEASE; BLAST CELL CRISIS; ENZYMOLOGY; GENETICS; LETTER; METABOLISM; MOLECULAR GENETICS; MYELOID LEUKEMIA; PATHOLOGY; PROGNOSIS;

ACUTE DISEASE; ANTIMETABOLITES, ANTINEOPLASTIC; BLAST CRISIS; CYTARABINE; HUMANS; LEUKEMIA, MYELOID; MOLECULAR SEQUENCE DATA; NUCLEOTIDASES; PROGNOSIS; RNA, MESSENGER;

EID: 2542444476     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Galmarini CM, Jordheim L, Dumontet C. Role of IMP-selective 5′-nucleotidase (cN-II) in hematological malignancies. Leuk Lymphoma 2003;44:1105-11.
2. Schirmer M, Stegmann AP, Geisen F, Konwalinka G. Lack of cross-resistance with gemcitabine and cytarabine in cladribine-resistant HL60 cells with elevated 5′-nucleotidase activity. Exp Hematol 1998;26:1223-8.
3. Dumontet C, Fabianowska-Majewska K, Mantincic D, Callet Bauchu E, Tigaud I, Gandhi V, et al. Common resistance mechanisms to deoxynucleoside analogues in variants of the human erythroleukaemic line K562. Br J Haematol 1999;106:78-85.
4. Galmarini CM, Graham K, Thomas X, Calvo F, Rousselot P, El Jafaari A, et al. Expression of high Km 5′-nucleotidase in leukemic blasts is an independent prognostic factor in adults with acute myeloid leukemia. Blood 2001;98:1922-6.
5. Galmarini CM, Thomas X, Graham K, El Jafaari A, Cros E, Jordheim L, et al. Deoxycytidine kinase and cN-II nucleotidase expression in blast cells predict survival in acute myeloid leukaemia patients treated with cytarabine. Br J Haematol 2003;122:53-60.
6. Rampazzo C, Johansson M, Gallinaro L, Ferraro P, Hellman U, Karlsson A, et al. Mammalian 5′(3′)-deoxyribonucleotidase, cDNA cloning, and overexpression of the enzyme in Escherichia coli and mammalian cells. J Biol Chem 2000;275:5409-15.
7. Mazzon C, Rampazzo C, Scaini MC, Gallinaro L, Karlsson A, Meier C, et al. Cytosolic and mitochondrial deoxyribonucleotidases: activity with substrate analogs, inhibitors and implications for therapy. Biochem Pharmacol 2003;66:471-9.
8. Galmarini CM, Mackey JR, Dumontet C. Nucleoside analogues: mechanisms of drug resistance and reversal strategies. Leukemia 2001;15:875-90.
9. Amici A, Emanuelli M, Magni G, Raffaelli N, Ruggieri S. Pyrimidine nucleotidases from human erythrocyte possess phosphotransferase activities specific for pyrimidine nucleotides. FEBS Lett 1997;419:263-7.
10. Amici A, Emanuelli M, Raffaelli N, Ruggieri S, Saccucci F, Magni G. Human erythrocyte pyrimidine 5-nucleotidase, PN-I, is identical to p36, a protein associated to lupus inclusion formation in response to α-interferon. Blood 2000;96:1596-8.